Drug Trial Radar · NCT03461146
Efficacy and Safety Study to Evaluate MT-6548 in Hemodialysis Subjects Not Receiving ESAs With Anemia Associated With Chronic Kidney Disease in Japan
Last checked: Nov 20, 2026Latest source record: Apr 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
24
Actual
Start
Mar 5, 2018
Primary completion
Dec 3, 2018
Study completion Dec 17, 2018
Sponsor
- Lead sponsor
- Tanabe Pharma CorporationIndustry
- Sponsor type
- Industry
- First posted
- Mar 9, 2018
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 20 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
For hemodialysis subjects not receiving ESAs with anemia associated with chronic kidney disease, evaluate Hb correction and maintenance effect and safety of MT-6548.
Conditions
- Anemia; Hemodialysis Dependent Chronic Kidney Disease
Interventions
MT-6548Drug
Oral tablet
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean Hb Level of Week 20 and Week 24Time frame: Up to Week 24
- Hb Level at Each Assessment Time PointTime frame: Up to Week 24
- Percentage of Subjects With Hb Level at Each Assessment Time Point Within the Target Range During the Treatment PeriodTime frame: Up to Week 24
- Time to Reach the Target Hb RangeTime frame: Up to Week 24
- Rate of Increase in Hb LevelTime frame: Up to Week 6
Locations
16 sites in 1 country. Site status is shown where the registry gives one.
Research site
Aichi, Japan
Research site
Chiba, Japan
Research site
Fukushima, Japan
Research site
Gunma, Japan
Research site
Hokkaido, Japan
Research site
Hyōgo, Japan
Research site
Ibaraki, Japan
Research site
Kagoshima, Japan
Research site
Nagano, Japan
Research site
Okayama, Japan
Research site
Okinawa, Japan
Research site
Osaka, Japan
Research site
Saitama, Japan
Research site
Shiga, Japan
Research site
Shizuoka, Japan
Research site
Yamagata, Japan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.